Today: 5 February 2026
Subscribe
Browse Category

Biotech News News 24 December 2025 - 30 December 2025

GMAB stock slides as Genmab scraps late-stage acasunlimab cancer therapy

GMAB stock slides as Genmab scraps late-stage acasunlimab cancer therapy

NEW YORK, December 30, 2025, 1:54 PM ET — Regular session Genmab A/S’s U.S.-listed shares (GMAB) fell 3.3% to $31.45 in Tuesday’s regular session. The stock traded between $31.40 and $32.06 after opening at $31.98, with about 1.9 million shares changing hands. The move keeps attention on Genmab’s pipeline as investors reassess which late-stage assets can power growth. Dropping a…
30 December 2025
·····
Corcept stock slides nearly 9% as FDA decision deadline arrives — what’s driving CORT today

Corcept stock slides nearly 9% as FDA decision deadline arrives — what’s driving CORT today

NEW YORK, December 30, 2025, 13:14 ET — Regular session Corcept Therapeutics Inc shares fell 8.9% to $72.72 in early afternoon Nasdaq trading on Tuesday, after touching a session low of $72.26. The stock was last down $7.10 from Monday’s close, with about 897,000 shares traded. The decline comes as investors focus on Corcept on the day the U.S. Food…
30 December 2025
·····
Edgewise Therapeutics stock steady midday after $3 million insider sale filing — what’s next for EWTX

Edgewise Therapeutics stock steady midday after $3 million insider sale filing — what’s next for EWTX

NEW YORK, December 30, 2025, 12:33 ET — Regular session Edgewise Therapeutics shares were up 0.2% at $24.68 as of 12:18 p.m. ET on Tuesday, after a Form 144 filing showed company officer Robert Michael Carruthers sold 116,665 shares worth about $3.04 million on Dec. 26. The stock traded between $24.40 and $24.92. SEC The disclosure matters because Edgewise is…
30 December 2025
·····
Pfizer filings spotlight big portfolio shifts as Live Oak slashes stake 92%

Pfizer filings spotlight big portfolio shifts as Live Oak slashes stake 92%

NEW YORK, December 29, 2025, 10:35 ET Live Oak Private Wealth LLC cut its stake in Pfizer (PFE.N) by 92.5% in the third quarter, selling 216,868 shares and ending the period with 17,627 shares, a regulatory filing showed. MarketBeat The disclosures matter because quarterly holdings reports are one of the few windows investors get into how money managers were positioned…
29 December 2025
·····
Eli Lilly stock steadies into Monday as $55 million ABL Bio funding keeps pipeline in focus

Eli Lilly stock steadies into Monday as $55 million ABL Bio funding keeps pipeline in focus

NEW YORK, December 28, 2025, 20:34 ET — Market closed Eli Lilly shares ended the holiday week little changed after South Korean biotech ABL Bio said it would receive $55 million in funding from the U.S. drugmaker under a research collaboration. PR Newswire The funding is small by Lilly standards, but it underscores how closely investors are tracking the company’s…
29 December 2025
·····
Regencell Bioscience (RGC) Stock: What to Know After a Sharp Friday Slide, Latest Headlines, and the Setup for Monday

Regencell Bioscience (RGC) Stock: What to Know After a Sharp Friday Slide, Latest Headlines, and the Setup for Monday

NEW YORK, Dec. 27, 2025, 7:48 PM ET — Market closed Regencell Bioscience Holdings Limited (Nasdaq: RGC) is heading into the final trading stretch of 2025 under a brighter spotlight after a volatile week capped by a steep Friday drop—one that stood out even as the broader U.S. market barely moved in a quiet, post-Christmas session. RGC last closed at…
28 December 2025
·····
Regencell Bioscience (RGC) Stock Slides 14% Into the Weekend: Latest News, Risks, and What to Watch Monday

Regencell Bioscience (RGC) Stock Slides 14% Into the Weekend: Latest News, Risks, and What to Watch Monday

NEW YORK, Dec. 27, 2025, 6:40 a.m. ET — Market closed Regencell Bioscience Holdings Limited (NASDAQ: RGC) stock heads into the weekend after a sharp Friday pullback, closing at $21.16, down 13.98% from the prior close of $24.60, in a move that put the name on multiple “top losers” radars as U.S. markets wrapped up a quiet post-Christmas session. Aaii…
27 December 2025
····
Edgewise Therapeutics (EWTX) Stock Today: EDG-7500 Safety Update, Analyst Targets, and What Investors Are Watching Next

Edgewise Therapeutics (EWTX) Stock Today: EDG-7500 Safety Update, Analyst Targets, and What Investors Are Watching Next

NEW YORK — Friday, December 26, 2025 (1:07 p.m. ET). U.S. stocks are trading in a post-holiday session with major benchmarks close to flat, while biotech is notably weaker. Against that backdrop, Edgewise Therapeutics, Inc. (NASDAQ: EWTX) is pulling back after a sharp midweek move tied to a clinical update in hypertrophic cardiomyopathy (HCM). As of the latest trade captured…
26 December 2025
·····
Regencell Bioscience (RGC) Stock Drops in Thin Post‑Christmas Trading as DOJ Probe and “Going Concern” Warning Keep Risk Front and Center

Regencell Bioscience (RGC) Stock Drops in Thin Post‑Christmas Trading as DOJ Probe and “Going Concern” Warning Keep Risk Front and Center

New York time check: It is Friday, December 26, 2025, 12:17 p.m. ET in New York. While the broader U.S. market is mostly drifting near record territory in subdued post‑holiday volume, Regencell Bioscience Holdings Limited (Nasdaq: RGC) is doing what it’s become famous for in 2025: moving a lot, on not much liquidity. AP News As of the most recently…
26 December 2025
··
Wave Life Sciences (WVE) Stock Today: Obesity Drug Catalyst, $402.5M Financing, and What Investors Are Watching Next

Wave Life Sciences (WVE) Stock Today: Obesity Drug Catalyst, $402.5M Financing, and What Investors Are Watching Next

New York, Dec. 26, 2025 (10:08 a.m. ET) — Wave Life Sciences Ltd. (NASDAQ: WVE) is trading at $18.12, down about 0.74% in the late morning session. The move comes while biotech is broadly softer—SPDR S&P Biotech ETF (XBI) is down about 1.07% and iShares Nasdaq Biotechnology ETF (IBB) is down about 0.63%—even as the broader market edges higher, with…
26 December 2025
·····
Omeros (OMER) Stock Surges After Hours on Dec. 24, 2025 After FDA Approves Yartemlea — What to Know Before the Next Market Open

Omeros (OMER) Stock Surges After Hours on Dec. 24, 2025 After FDA Approves Yartemlea — What to Know Before the Next Market Open

Omeros Corporation (NASDAQ: OMER) is ending Christmas Eve 2025 as one of the market’s most volatile and news-driven movers after the U.S. Food and Drug Administration approved the company’s first commercial product — a moment investors have waited years to see. As of 2:35 p.m. ET in after-hours trading on Wednesday, Dec. 24, 2025, OMER stock traded around $15.36, up…
24 December 2025
·····
Travere Therapeutics (TVTX) Stock Jumps on Dec. 24, 2025: 52-Week High, FDA Catalyst Ahead, and Analyst Price Targets

Travere Therapeutics (TVTX) Stock Jumps on Dec. 24, 2025: 52-Week High, FDA Catalyst Ahead, and Analyst Price Targets

Travere Therapeutics, Inc. (NASDAQ: TVTX) is ending 2025 with a bang. In the holiday-shortened U.S. trading session on Wednesday, December 24, 2025, TVTX surged sharply—pushing to fresh highs as investors recalibrated around two big themes: accelerating commercial execution for FILSPARI (sparsentan) and a looming FDA decision that could expand the drug into a second major kidney disease indication. StockAnalysis TVTX…
24 December 2025
·····
1 … 4 5 6 7 8 … 12

Stock Market Today

  • Corn Futures Edge Higher Amid Export Sales and Ethanol Production Data
    February 5, 2026, 11:00 AM EST. Corn futures held slight gains midday, with cash corn prices up 1.25 cents to $3.95 1/2. A private export sale of 130,480 metric tons (MT) was reported to unknown destinations, while a South Korean importer bought 65,000 MT in a private tender. Ethanol production fell by 158,000 barrels per day (bpd) to 956,000 bpd last week, with stocks down 264,000 barrels. Exports rose 59,000 bpd. Traders anticipate USDA weekly sales data on Thursday, expecting 0.8-2.1 million MT sold for the week ending Jan. 29. March corn futures stood at $4.29 1/2, up 1 cent, with May and July 2026 contracts also posting modest gains. These moves reflect cautious optimism amid fluctuating demand and production shifts in related markets.
Go toTop